approval
saveGAZYVA (OBINUTUZUMAB) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalDec 17, 2025 · 288d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalOct 17, 2025 · 349d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalOct 17, 2025 · 349d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalJul 27, 2022 · 1527d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalJul 12, 2022 · 1542d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalMar 27, 2020 · 2379d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalNov 16, 2017 · 3241d ago
- approvalGAZYVA (OBINUTUZUMAB) — FDA approvalNov 16, 2017 · 3241d ago
same company · ±60 days · 5
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalFeb 2, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalFeb 28, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalFeb 28, 2022
- approvalfaricimab: VABYSMO (FARICIMAB-SVOA) — FDA approvalJan 28, 2022
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalJan 21, 2022
comments(0)
5-min edit window · permanent after that